Concepedia

Beneficial Effects of Adding Spironolactone to Recommended Antihypertensive Treatment in Diabetic Nephropathy

Kasper Rossing, K. J. Schjoedt, U. Smidt, Frans Boomsma, Hans‐Henrik Parving

Diabetes Care · 2005 · 293 citations · 37 references

DOIFull text

Open access

Abstract

Our study suggests that spironolactone safely adds to the reno- and cardiovascular protective benefits of treatment with maximally recommended doses of ACE inhibitor and ARB by reducing albuminuria and blood pressure in type 2 diabetic patients with nephropathy.

References

37

Mixed-Effects Models in S and S-PLUS

Technometrics · 2001 · 9.4K citations · Full text

The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure

Bertram Pitt, Faı̈ez Zannad, Willem J. Remme et al. · New England Journal of Medicine · 1999 · 9K citations · Full text

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.4K citations · Full text

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

UK Prospective Diabetes Study Group · BMJ · 1998 · 6.7K citations · Full text

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 5.9K citations · Full text